Significance of Magnetic Resonance Imaging in Apical Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 105, Issue 11, 2010, Pages 1592-1596

  Fattori, Rossella ^a   Biagini, Elena ^a   Lorenzini, Massimiliano ^a   Buttazzi, Katia ^a   Lovato, Luigi ^a   Rapezzi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; T WAVE INVERSION;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM; HEART ANEURYSM; HEART VENTRICLES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INCIDENCE; ITALY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 77952423393     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.020     Document Type: Article

References (17)

1. Sakamoto T. Apical hypertrophic cardiomyopathy (apical hypertrophy): an overview. J Cardiol 37 (2001) 161-178
2. Eriksson M.J., Sonnenberg B., Woo A., Rakowski P., Parker T.G., Wigle E.D., and Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39 (2002) 638-645
3. Budoff M.J., Cohen M.C., Garcia M.J., Hodgson J.M., Hundley W.G., Lima J.A., Manning W.J., Pohost G.M., Raggi P.M., Rodgers G.P., Rumberger J.A., Taylor A.J., Creager M.A., Hirshfeld Jr. J.W., Lorell B.H., Merli G., Rodgers G.P., Tracy C.M., Weitz H.H., American College of Cardiology Foundation, American Heart Association, American College of Physicians Task Force on Clinical Competence and Training, American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging, and Society for Cardiovascular Angiography and Interventions. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol 46 (2005) 383-402
4. Moon J.C., Reed E., Sheppard M.N., Elkington A.G., Ho S.Y., Burke M., Petrou M., and Pennell D.J. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
5. Moon J.C., Fisher N.G., McKenna W.J., and Pennel D.J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non diagnostic echocardiography. Heart 90 (2004) 645-649
6. Yamada M., Teraoka K., Kawade M., Hirano M., and Yamashina A. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study. Int J Cardiovasc Imaging 25 (2009) 131-138
7. Suzuki J., Watanabe F., Takenaka K., Amano K., Amano W., Igarashi T., Aoki T., Serizawa T., Sakamoto T., Sugimoto T., et al. New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T-waves. J Am Coll Cardiol 22 (1993) 1175-1181
8. Maron M.S., Finley J.J., Bos J.M., Hauser T.H., Manning W.J., Haas T.S., Lesser J.R., Udelson J.E., Ackerman M.J., and Maron B.J. Prevalence, clinical significance and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118 (2008) 1541-1549
9. Nakamura T., Matsubara K., Furukawa K., Azuma A., Sugihara H., Katsume H., and Nakagawa M. Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19 (1992) 516-524
10. Matsubara K., Nakamura T., Kuribayashi T., Azuma A., and Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42 (2003) 288-295
11. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., Lesser J.R., Hanna C.A., Udelson J.E., Manning W.J., and Maron M.S. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
12. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
13. Sato Y., Matsumoto N., Kunimasa T., Matsuo S., Yoda S., Tani S., Kunimoto S., Saito S., and Hirayama A. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging. Int J Cardiol 131 (2008) e41-e43
14. Efthimiadis G.K., Spanos G.P., Giannakoulas G., Boufidou A., Parcharidou D.G., Karvounis H., Styliadis I., and Parcharidis G.E. Hypertrophic cardiomyopathy with late enhancement of the non-hypertrophied left ventricular segments. Hellenic J Cardiol 49 (2008) 114-116
15. Strijack B., Ariyarajah V., Soni R., Jassal D.S., Greenberg C.R., McGregor R., and Morris A. Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype. J Cardiovasc Magn Reson 10 (2008) 58
16. Marian A.J. pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 355 (2000) 58-60
17. Lim D.S., Lutucuta S., Bachireddy P., Youker K., Evans A., Entman M., Roberts R., and Marian A.J. Angiotensin II blockade reverses myocardial fibrosis in transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103 (2001) 789-791